Market Cap (In HKD)
33.61 Million
Revenue (In HKD)
181.09 Million
Net Income (In HKD)
-39.97 Million
Avg. Volume
100.58 Thousand
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.042-0.095
- PE
- -
- EPS
- -
- Beta Value
- 0.198
- ISIN
- KYG9431A1186
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Mr. Jia Jun Wang
- Employee Count
- -
- Website
- https://www.wanjia-gp.com
- Ipo Date
- 2013-10-11
- Details
- Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
More Stocks
-
DSFGY
-
0HURCelanese Corporation
0HUR
-
LFINLongfin Corp.
LFIN
-
EKGGF
-
600804
-
0JR2Kinder Morgan, Inc.
0JR2
-
PHMMFPharma Mar, S.A.
PHMMF
-
SYH